Compound Evidence File
#EC-2026-0540
BPC 500mcg + TB500 500mcg Blend Oral
Filed under Oral Tablets. The bureau holds 127 laboratory returns for this compound from 42 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
42 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 10 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 10.0 | 10.0 | 10 May 2026 | 12 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 10.0 | 10.0 | 19 May 2026 | 3 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 10.0 | 10.0 | 28 Dec 2025 | 10 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 23 Apr 2026 | 16 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 28 Dec 2025 | 25 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 19 May 2026 | 24 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 10.0 | 10.0 | 10.0 | 2 Nov 2025 | 27 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 21 Dec 2025 | 1 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 10.0 | 10.0 | 10.0 | 27 Mar 2026 | 2 Jul 2026 |
| Pure RawzCASE #VI-2026-0767 | X | 1 | 10.0 | 10.0 | 10.0 | 24 Apr 2025 | 24 Apr 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 10.0 | 10.0 | 10.0 | 2 Jul 2025 | 2 Jul 2025 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 23 May 2026 | 5 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 10.0 | 19 May 2026 | 7 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 27 Dec 2025 | 18 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 8 Nov 2025 | 1 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 10.0 | 17 Feb 2026 | 5 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 10 Feb 2026 | 2 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 10 Feb 2026 | 10 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 9.9 | 9.9 | 10.0 | 8 Nov 2025 | 28 Mar 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 9.9 | 9.9 | 9.9 | 22 Apr 2026 | 1 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 9.9 | 19 May 2026 | 21 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 10 Jun 2026 | 22 Jun 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 9.6 | 8.4 | 10.0 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 3 | 9.5 | 8.6 | 10.0 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.9 | 7.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.6 | 7.3 | 10.0 | 25 May 2026 | 25 May 2026 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 8.3 | 8.3 | 8.3 | 2 Apr 2025 | 2 Apr 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.0 | 6.0 | 9.8 | 24 May 2026 | 24 May 2026 |
| Atomik LabzCASE #VI-2026-0327 | X | 3 | 7.8 | 7.1 | 8.5 | 13 Jun 2025 | 24 May 2026 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 2 | 7.3 | 7.1 | 7.5 | 6 May 2025 | 24 May 2026 |
| PeptidologyCASE #VI-2026-0520 | X | 1 | 7.0 | 7.0 | 7.0 | 16 Mar 2025 | 16 Mar 2025 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 6 | 6.5 | 5.5 | 8.3 | 7 May 2025 | 25 May 2026 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 6.0 | 4.6 | 7.4 | 2 Apr 2025 | 26 Jan 2026 |
| NextechLabsCASE #VI-2026-0285 | X | 1 | 5.4 | 5.4 | 5.4 | 3 Jun 2025 | 3 Jun 2025 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 5.2 | 5.2 | 5.2 | 20 Jun 2025 | 20 Jun 2025 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 5.1 | 5.1 | 5.1 | 21 May 2025 | 21 May 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 2 | 3.1 | 2.2 | 4.1 | 14 Jan 2025 | 24 May 2026 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 2.3 | 2.3 | 2.3 | 13 Jun 2025 | 13 Jun 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jul 2025 | 3 Jul 2025 |
Open any subject to view the batch-level evidence for BPC 500mcg + TB500 500mcg Blend Oral alone.